NuGene International Price To Sales vs. Current Valuation

NUGN Stock  USD 0.01  0  25.00%   
Taking into consideration NuGene International's profitability measurements, NuGene International may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess NuGene International's ability to earn profits and add value for shareholders.
For NuGene International profitability analysis, we use financial ratios and fundamental drivers that measure the ability of NuGene International to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well NuGene International utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between NuGene International's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of NuGene International over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Please note, there is a significant difference between NuGene International's value and its price as these two are different measures arrived at by different means. Investors typically determine if NuGene International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NuGene International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

NuGene International Current Valuation vs. Price To Sales Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining NuGene International's current stock value. Our valuation model uses many indicators to compare NuGene International value to that of its competitors to determine the firm's financial worth.
NuGene International is considered to be number one stock in price to sales category among its peers. It also is rated top company in current valuation category among its peers reporting about  1,536,326  of Current Valuation per Price To Sales. Comparative valuation analysis is a catch-all model that can be used if you cannot value NuGene International by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for NuGene International's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

NuGene Current Valuation vs. Price To Sales

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

NuGene International

P/S

 = 

MV Per Share

Revenue Per Share

 = 
9.65 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

NuGene International

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
14.83 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

NuGene Current Valuation vs Competition

NuGene International is rated top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Shell Companies industry is now estimated at about 117.22 Million. NuGene International retains roughly 14.83 Million in current valuation claiming about 13% of equities listed under Shell Companies industry.

NuGene International Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in NuGene International, profitability is also one of the essential criteria for including it into their portfolios because, without profit, NuGene International will eventually generate negative long term returns. The profitability progress is the general direction of NuGene International's change in net profit over the period of time. It can combine multiple indicators of NuGene International, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Livento Group, Inc. engages in the film and television production activities. Livento Group, Inc. was incorporated in 2013 and is based in New York, New York. Nugene International operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 11 people.

NuGene Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on NuGene International. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of NuGene International position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the NuGene International's important profitability drivers and their relationship over time.

Use NuGene International in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NuGene International position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NuGene International will appreciate offsetting losses from the drop in the long position's value.

NuGene International Pair Trading

NuGene International Pair Trading Analysis

The ability to find closely correlated positions to NuGene International could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NuGene International when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NuGene International - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NuGene International to buy it.
The correlation of NuGene International is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NuGene International moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NuGene International moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NuGene International can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your NuGene International position

In addition to having NuGene International in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Financials Thematic Idea Now

Financials
Financials Theme
Companies that provide financial services to business or retail customers. The Financials theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in NuGene Pink Sheet

To fully project NuGene International's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of NuGene International at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include NuGene International's income statement, its balance sheet, and the statement of cash flows.
Potential NuGene International investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although NuGene International investors may work on each financial statement separately, they are all related. The changes in NuGene International's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on NuGene International's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.